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Abstract
Background: Blood is a complex tissue comprising numerous cell types with distinct functions
and corresponding gene expression profiles. We attempted to define the cell type specific gene
expression patterns for the major constituent cells of blood, including B-cells, CD4+ T-cells, CD8+
T-cells, lymphocytes and granulocytes. We did this by comparing the global gene expression
profiles of purified B-cells, CD4+ T-cells, CD8+ T-cells, granulocytes, and lymphocytes using cDNA
microarrays.
Results:  Unsupervised clustering analysis showed that similar cell populations from different
donors share common gene expression profiles. Supervised analyses identified gene expression
signatures for B-cells (427 genes), T-cells (222 genes), CD8+ T-cells (23 genes), granulocytes (411
genes), and lymphocytes (67 genes). No statistically significant gene expression signature was
identified for CD4+ cells. Genes encoding cell surface proteins were disproportionately
represented among the genes that distinguished among the lymphocyte subpopulations.
Lymphocytes were distinguishable from granulocytes based on their higher levels of expression of
genes encoding ribosomal proteins, while granulocytes exhibited characteristic expression of
various cell surface and inflammatory proteins.
Conclusion: The genes comprising the cell-type specific signatures encompassed many of the
genes already known to be involved in cell-type specific processes, and provided clues that may
prove useful in discovering the functions of many still unannotated genes. The most prominent
feature of the cell type signature genes was the enrichment of genes encoding cell surface proteins,
perhaps reflecting the importance of specialized systems for sensing the environment to the
physiology of resting leukocytes.
Background
Circulating leukocytes are a rich and readily accessible
source of information about the health and physiological
state of an individual. A procedure as simple as light
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microscopy-based quantitation of morphologically dis-
tinguishable blood cell types is so broadly useful that it
has been a mainstay of clinical diagnosis for decades.
Methods that might resolve more subtle variations in leu-
kocytes could have correspondingly greater diagnostic
power [1]. To explore and develop this potential, gene
expression profiling of peripheral blood cells has become
an increasingly popular means of addressing a wide vari-
ety of questions about health and disease. This approach
has been used to study numerous states of health includ-
ing multiple sclerosis, renal cell carcinoma, stroke, small-
pox, neurofibromatosis type 1, and responses to various
stresses [2-8] in the hopes of developing easily assayable
prognostic or diagnostic markers, and gaining insight into
disease mechanisms, as well as to the study of natural var-
iation and individuality in gene expression [9-11]. While
many of these studies have been successful in identifying
gene expression patterns that differentiate control and dis-
ease groups, their interpretation is often confounded by
variation in relative proportions of the cell populations
that make up whole blood.
Blood is a complex tissue, containing a variety of cell types
– including T-cells, B-cells, monocytes, NK cells, and gran-
ulocytes, each of which can be further subdivided. The rel-
ative proportion of each of these cell types can vary greatly
between individuals and with states of health and disease,
and in response to stimuli. In whole blood, neutrophils
are usually the most abundant cell type, normally varying
in abundance from 30–70% of white blood cells in
healthy adults [12,13] and even more (or less) in disease.
Neutrophils are often excluded from analyses of gene
expression in human blood, but the remaining mixture of
peripheral blood mononuclear cells (PBMC), can also
vary greatly in its composition. In healthy adults, mono-
cytes can vary from 2 to 10% of PBMCs [12], and within
the lymphocyte subset, the relative proportion of T-lym-
phocytes and B-lymphocytes can range from 61–85% and
7–23% respectively [14]; furthermore, the ratio of CD4+
T-cells to CD8+ T-cells can vary from <1.0 to 2.0 [15]. The
relative proportions of the contributing cell types inevita-
bly affect the composite gene expression profiles of whole
blood or unfractionated PBMCs. Variation in the relative
proportions of distinct cell types provides valuable clini-
cal information in its own right. The ability to distinguish
the effects of variation in cellular "demographics" from
the signatures of physiological responses, in global gene
expression profiles of peripheral blood samples, would
thus undoubtedly improve our ability to extract physio-
logical and clinical insights from these signatures.
By comparing gene expression profiles of homogeneous
cell populations, it is possible to identify genes with cell-
type-specific gene expression patterns. These sets of genes
can serve as "biomarkers" for estimating the abundance of
specific cell types, and can provide insights into cellular
functioning. By sorting peripheral blood from healthy
donors based on cell surface markers, we obtained puri-
fied populations of CD4+ T-cells, CD8+ T-cells, and B-
cells. We then compared the global gene expression pro-
files of these purified populations, PBMCs and whole
blood samples, and attempted to identify cell-type-spe-
cific signatures for B-cells, T-cells, CD4+ T-cells, CD8+ T-
cells, lymphocytes, and granulocytes.
Results and discussion
Overview
We used DNA microarrays containing 37,632 elements
representing ~18,000 genes to characterize the global
gene expression profiles for 9 B-cell, 6 CD8+ T-cell, 5
CD4+ T-cell, 5 PBMC and 3 whole blood samples, repre-
senting 3 female and 4 male healthy adults. In order to
obtain an overview of the major sources of variation in
this data set, we selected a set of variably expressed genes
(741 genes/1109 clones whose transcripts levels varied
3.0 fold or more from the mean across all samples, in at
least 3 of the 28 samples) and clustered the samples and
genes using these genes.
As shown in Figure 1, hierarchical clustering separated the
samples into four main groups: B-cells, T-cells, whole
blood, and PBMCs; notably, the two purified T-cell sub-
sets (CD4+ and CD8+ T-cells) were intermingled. This
analysis revealed sets of genes whose transcripts are char-
acteristically expressed by specific cell types. The set of
genes preferentially expressed in B-cells included many
genes encoding immunoglobulins and proteins involved
in MHC class II antigen processing and presentation,
while the set of genes most highly expressed in T-cells was
rich in genes encoding the T-cell receptor complex and
associated signaling molecules. Both the B and T-cell
enriched gene clusters also included cytokine receptors
and cell adhesion receptors known to have cell-type-spe-
cific expression. The transcripts enriched in the whole
blood samples appeared to reflect the transcriptional pro-
gram of neutrophils, which are abundant in whole blood
yet virtually absent from the lymphocyte and PBMC sam-
ples. This gene cluster included transcripts encoding sev-
eral Fc receptors and granulocyte-specific cytokine
receptors. The cluster of genes with the lowest relative
expression in whole blood revealed genes more highly
expressed in lymphoid than in myeloid cells. This cluster
was almost entirely composed of ribosomal genes and
other genes involved in translation. There were three dis-
tinct gene clusters that were not associated with a specific
cell type. The first was a small gender-associated cluster,
with the expected elevated expression of Y-linked genes in
males, and of XIST in females. The second was a "stress
response" associated cluster, which contained a set of
genes known to be easily activated in response to ex-vivoBMC Genomics 2006, 7:115 http://www.biomedcentral.com/1471-2164/7/115
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Overview of hierarchical clustering of all samples Figure 1
Overview of hierarchical clustering of all samples. Hierarchically clustered gene expression profiles of 28 mixed and 
purified leukocyte samples. Results for ~741 genes with high variation in transcript levels among these samples. Genes and 
blood samples are organized by hierarchical clustering based on overall similarity in expression patterns. Expression levels are 
represented by a color key in which bright red represents the highest levels and bright green represents the lowest levels, and 
less saturated shades represent intermediate levels of expression. Values were centered across all samples to a mean of zero. 
Clusters of genes are labeled according to which samples have the highest relative gene expression.
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handling and a variety of other stresses [16]. This set of
genes was most highly activated in samples from female 3,
all of which were obtained during the first (and longest)
isolation experiment, and expressed at the lowest levels in
the whole blood samples, which were subject to the least
manipulation. A final small but prominent cluster was the
hemoglobins – alpha, beta, and zeta. These were highly
expressed in the whole blood samples and in a subset of
the B-cell samples, corresponding to those B-cell samples
that were purified by negative selection (depletion of non-
B-cells) rather than positive selection and presumably rep-
resented the relative proportion of RBCs in these samples.
There were no other consistent differences between the
positively and negatively selected B-cells, although the lat-
ter were less pure than the positively selected B-cells and
had noticeably more red blood cell contamination. All T-
cell samples were obtained by negative selection in order
to minimize cell stimulation [17]. See Additional file 1 for
the complete data set.
For each cell population of interest (B-cells, T-cells, CD4+
T-cells, CD8+ T-cells, granulocytes and lymphocytes), we
also performed a supervised search for genes that are char-
acteristically expressed by that cell type. Specifically, for
each cell type, we searched for genes whose expression
was significantly positively correlated with the estimated
relative abundance of the cell type across the set of 28
samples of varying cell type composition (p < 0.005 by
permutation). We refined these gene lists by also requir-
ing that a signature gene discriminate between the target
cell and a closely related cell population (T-cells versus B-
cells; CD4+ T-cells versus CD8+ T-cells; whole-blood ver-
sus PBMC), using a two-class Significance Analysis of
Microarrays (SAM) [18] (False Discovery Rate < = 5%). We
analyzed the final cell type specific gene lists for func-
tional and structural themes using EASE [19], a program
for calculating the statistical enrichment of Gene Ontol-
ogy (GO) [20] annotations in a query list relative to a
background list (Bonferroni p < 0.05 for Fisher's Exact
Test).
B-lymphocytes
B-lymphocytes function primarily in humoral (antibody-
mediated) immunity, and comprise approximately 15%
of lymphocytes in healthy adults. We derived a B-cell sig-
nature by searching for genes that met the following crite-
ria: I) their expression was significantly positively
correlated with relative abundance of B-cells across all
samples II) their expression was significantly different in
B-cells than T-cells (by SAM) and III) they were at least 2-
fold more highly expressed in B-cells than in T-cells. Using
these criteria, we identified 427 "B-cell signature" genes
(represented by 814 clones) (Figure 2). This signature set
included numerous genes encoding classical B-cell associ-
ated genes including B-cell co-receptor molecules (CD19,
CD21, CD22, FCGR2B) [21], other B-cell surface markers
(CD20, CD24, CD38, CD72, CD74, CD79A/B, CD83,
CD86) [22], immunoglobulins (IG gamma, kappa,
lambda; light and heavy), MHC class II receptors (HLA-
DM/O/P/Q/R), signal transduction molecules (SYK, LYN,
BTK, BLNK, BLK) and transcriptional regulators (EBF,
PAX5/BSAP, OBF1/POU2AF1, SPIB, PU.1/SPI1, IRF4,
IRF8, CEBPB) [23]. We analyzed the B-cell signature with
EASE, and confirmed that the most enriched GO annota-
tions were those relating to classical B-cell functions such
as "antigen binding", "antigen processing", "antigen pres-
entation", and "MHC Class II receptor activity". The only
significantly enriched GO annotations relating to cellular
component were "integral to membrane" and "mem-
brane", which is consistent with the importance of inter-
actions with the external environment in defining the
unique characteristics of the B-cell. The complete list of B-
cell specific genes, and results from EASE analysis are
available as supplemental data (see Additional file 2 for
gene list and Additional file 3 for EASE results).
T-lymphocytes
T-lymphocytes function primarily in cell-mediated immu-
nity, and comprise approximately 70% of lymphocytes.
We derived a T-cell signature by searching for genes that
met the following criteria: I) their expression was signifi-
cantly positively correlated with the relative abundance of
T-cells (CD4+ or CD8+) across all samples II) their expres-
sion was significantly different between T-cells and B-cells
(by SAM) and III) they were at least 2-fold more highly
expressed in T-cells than in B-cells. Using these criteria, we
identified 222 "T-cell signature" genes (represented by
370 clones) (Figure 3). This gene set encompassed many
of the T-cell receptor and associated signal transduction
genes (CD3δ/γ, CD28, TRα/β, MAL, LAT, TCRIM, FYN,
ZAP70) [24] and also included genes encoding important
T-cell transcriptional regulators (GATA3, LEF1, TCF7,
RUNX2, STAT4, SATB1) [25] and cell adhesion molecules
(CD2, CD5, CD6). The most enriched GO annotations
(as determined with EASE) included the cellular compo-
nent "T-cell receptor complex", the biological process
"signal transduction", and the molecular function "recep-
tor activity", suggesting that T-cells are best distinguished
from other cell types based on their cell surface receptors
and associated signal transduction genes.
We compared our list of 222 T-cell enriched genes with a
recently published list of 92 "T-cell enriched" genes [26],
and found that 33 of the 81 genes on this list that were
also measured in our study, were also identified as T-cell
enriched in this study (P < 10-41, hypergeometric distribu-
tion probability of > = 33 T-cell genes/81 genes given pop-
ulation ratio of 222 T-cell genes/16865 genes measured).
The genes identified in common by the two studies
tended to be classical T-cell associated genes with high dis-BMC Genomics 2006, 7:115 http://www.biomedcentral.com/1471-2164/7/115
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crimination rankings in both studies. This overlap is espe-
cially striking in view of the fact that the two studies used
different microarray platforms (two color comparative
cDNA hybridization versus one color Affymetrix oligonu-
cleotide arrays) and, more importantly, the different selec-
tion criteria for T-cell specificity – we required
discrimination of T-cells from B-cells as well as a signifi-
cantly positive correlation between a gene's expression
and T-cell abundance across all mixed and purified sam-
ples, whereas Cobb et al. required only discrimination
between of T-cells and mixed blood cells. The complete
list of T-cell specific genes and the results of EASE analysis
B-cell signature genes Figure 2
B-cell signature genes. Relative expression of B-cell signature genes is shown for all samples. Genes (rows) are sorted in 
descending order of correlation of gene expression with relative abundance of B-cells. Samples (columns) are ordered in 
decreasing order of estimated relative abundance of B-cells from left to right. The grayscale bar on top shows the estimated 
relative abundance of B-cells in each class of samples – black indicates 100% relative abundance of B-cells, white indicates 0% 
relative abundance of B-cells, and grey indicates intermediate relative abundance of B-cells. Gene expression values are cen-
tered across all samples to a median of zero. All genes mentioned in the text are listed in order of correlation with B-cell abun-
dance and black bars indicate their positions in the figure.
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are available as supplemental data (see Additional file 2
for gene list and Additional file 3 for EASE results).
CD8+ T-cells
CD8+ T-lymphocytes, or cytotoxic T-lymphocytes (CTLs)
are involved in cell-mediated cytotoxic reactions, and
comprise approximately 35% of T-lymphocytes. We
derived a list of CD8+ T-cell specific genes by searching for
genes that met the following criteria: I) their expression
was significantly positively correlated with relative abun-
dance of CD8+ T-cells across all samples II) their expres-
sion was significantly different between CD8+ T-cells and
CD4+ T-cells (by SAM) and III) they were at least 2 fold
more highly expressed in CD8+ T-cells than in CD4+ T-
cells. Using these criteria, we identified 23 "CD8+ signa-
ture" genes (represented by 32 clones) (Figure 4). The
CD8+ T-cell signature included genes encoding plasma
membrane receptors (CD8A/B, IL2RB, KLRC1, KLRG1),
cytotoxicity-associated genes (PRF1, GNLY, GZMC/H),
and other genes (CCL5/RANTES, T-bet/TBX21, CST7)
known to be expressed by CD8+ T-cells [27,28]. The most
enriched GO annotations (by EASE analysis) included the
cellular component "T-cell receptor complex" and the
molecular function "MHC class1 protein binding". CD8+
T-cells appear to be best distinguished from CD4+ T-cells
and other cell types based on their cell surface profile and
expression of genes encoding proteins with cytolytic func-
tions. While many of the CD8+ T-cell signature genes are
also expressed by NK cells [27,29], this signature remains
a useful description of the transcriptional activities of rest-
ing CD8+ T-cells. The complete list of CD8+ T-cell specific
genes and the results of EASE analysis are available as sup-
plemental data (see Additional file 2 for gene list and
Additional file 3 for EASE results)
T-cell signature genes Figure 3
T-cell signature genes. Relative expression of T-cell signature genes is shown for all samples. Genes (rows) are sorted in 
descending order of correlation of gene expression with relative abundance of T-cells. Samples (columns) are ordered in 
decreasing relative abundance from left to right. Gene expression values are centered across all samples to a median of zero. 
The grayscale bar on top shows the estimated relative abundance of T-cells in each class of samples – black indicates 100% rel-
ative abundance of T-cells, white indicates 0% relative abundance of T-cells, and grey indicates intermediate relative abundance 
of T-cells. All genes mentioned in the text are listed in order of correlation with T-cell abundance, and black bars indicate their 
positions in the figure.
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CD4+ T-cells
The majority of T-lymphocytes are CD4+ "helper" T-cells
(the average CD4+/CD8+ T-cell ratio is 1.8) [14], and
function primarily in the activation of B-cells and macro-
phages. We attempted to define CD4+ T-cell specific genes
by searching for genes that met the following criteria: I)
their expression was significantly positively correlated
with relative abundance of CD4+ T-cells across all sam-
ples II) their expression was significantly different
between CD4+ T-cells and CD8+ T-cells (by SAM) and III)
they were at least 2 fold more highly expressed in CD4+ T-
cells than in CD8+ T-cells. There were no genes that met
all three criteria. Notably, SAM analysis (CD4+ T-cells ver-
sus CD8+ T-cells) alone only yielded 4 genes: CD4, ANK3,
MXI1, and CTSB. All four genes were more than 2 fold
enriched in CD4+ T-cells relative to CD8+ T-cells but only
two of these genes (CD4 and ANK3) were also signifi-
cantly positively correlated with the relative abundance of
CD4+ T-cells across all samples. However, since the
majority of clones representing CD4 and ANK3 (3 of 4
clones and 2 of 3 clones respectively) did not meet all of
the above criteria, these genes did not meet our final crite-
rion of clone consistency (see Methods), and thus did not
qualify as CD4+ T-cell "signature" genes (although 2 of
the 4 "discordant" CD4 clones did meet the correlation
criteria alone). The failure of most CD4 clones to meet our
selection criteria may be explained by the fact that CD4
itself is not exclusively expressed by CD4+ T-cells – it is
also expressed by monocytes (at lower levels) [30] and by
some neutrophils [31]. The one-sidedness of the CD8+ T-
cell: CD4+ T-cell comparison suggests that CD8+ and
CD4+ T-cells share much of their cellular machinery, and
that CD4+ T-cells begin transcription of their effector mol-
ecules only upon stimulation while CD8+ T-cells appear
to prepare some of their cytotoxic artillery in advance.
This result is in contrast to a study of the gene expression
profiles of CD4+ and CD8+ T-cells in response to activa-
tion, in which as many as 518 genes were found to be pref-
erentially expressed by either CD8+ T-cells or CD4+ T-
cells [32].
Granulocytes
Granulocytes, specifically neutrophils, are the most abun-
dant cells in whole blood, but are virtually absent in
CD8+ T-cell signature genes Figure 4
CD8+ T-cell signature genes. Relative expression of CD8+ T-cell signature genes is shown for all samples. Genes (rows) 
are sorted in descending order of correlation of gene expression with relative abundance of T-cells. Samples (columns) are 
ordered in decreasing relative abundance from left to right. The grayscale bar on top shows the estimated relative abundance 
of CD8+ T-cells in each class of samples – black indicates 100% relative abundance of CD8+ T-cells, white indicates 0% relative 
abundance of CD8+ T-cells, and grey indicates intermediate relative abundance of CD8+ T-cells. Gene expression values are 
centered across all samples to a median of zero. All genes mentioned in the text are listed and their position is marked with a 
black bar.
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PBMC samples. They are short-lived, terminally differen-
tiated phagocytic cells involved in innate immunity and
acute inflammatory responses. We obtained a granulocyte
signature gene list by searching for genes that met the fol-
lowing criteria: I) their expression was significantly posi-
tively correlated with relative abundance of granulocytes
across all (mixed and purified) samples II) their expres-
sion was significantly different between whole blood sam-
ples and PBMC samples (by SAM) and III) they were at
least 2 fold more highly expressed in whole blood than in
PBMCs. We assumed that transcripts more abundant in
whole blood than in PBMC samples are most likely to be
derived from neutrophils, the most abundant granulo-
cyte, but they could also could also be derived from eosi-
nophils, basophils, platelets, or reticulocytes, because
these cell types are also significantly depleted in PBMC rel-
ative to whole blood. Using these criteria, we identified
411 putative granulocyte signature genes (represented by
557 clones) (Figure 5). The granulocyte signature con-
tained numerous genes encoding cell surface proteins
including: cytokine receptors (CSF2RB, CSF3R, IL1R2,
IL1RN, IL8RB, IL13RA1), Fc and complement receptors
(FCGRT, FCGR3B/CD16, C3AR1), chemotactic receptors
(FPR1, CD10/MME), and EMR2, a recently characterized
class B seven-span transmembrane (TM7) receptor,
reported to have myeloid specific gene expression [33].
Many of the remaining granulocytes-enriched genes were
involved in intracellular pathogen destruction (GCA,
PRG1, NCF2, DEFA1, cathepsins B/C/S) or inflammatory
mediation (PBEF, MNDA). A number of the genes on this
list have been previously shown to be expressed in
unstimulated circulating neutrophils (AQP9, BCL6,
CD10/MME, CSF2RB, CSF3R, DEFA1, FCGR3B, FPR1,
GCA, GNB2, ICAM3, IFITM2, IL8RB, ITM2B, MNDA,
NCF2, PBEF, PRG1, RASSF2, RGS2, SOD2, TALDO1,
VNN2) [34,35]. The only GO annotations that we identi-
fied as statistically enriched with EASE were general bio-
logical processes including "inflammatory response" and
"innate immune response".
We compared our results to those of a previously pub-
lished study that also compared whole blood and PBMC
samples, and found significant overlap between the two
studies. Whitney et al. [11] found 704 "granulocyte
enriched" genes with mean differences of greater than 2
fold in expression between whole blood and PBMC sam-
ples from the same individual. Of the 660 genes in this set
that were measured in our study, 171 were also classified
as granulocyte signature genes in this study (P < 10-135,
hypergeometric distribution probability of > = 171 granu-
locyte genes/660 genes given population ratio of 411
granulocyte genes/16865 genes measured). The concord-
ant genes tended to be those with higher discrimination
scores in both studies. The imperfect overlap of the two
gene lists is not unexpected because different filtering cri-
teria were used – the 2 fold change required by Whitney et
al. was one of three criteria in our study. We tested the
applicability of our "granulocyte enriched" gene list in an
independent data set of 77 whole blood samples from 75
subjects for which the relative abundance of neutrophils
was known [11]. For each of the 17046 well-measured
clones in this independent data set, we calculated the
Pearson correlation of gene expression to neutrophils rel-
ative abundance, and converted these correlations to per-
centile rank correlations. We found that the genes in our
granulocyte signature had a median Pearson correlation
of 0.17 and a median percentile rank of 0.91 in the other
data set, suggesting that the genes in our granulocyte sig-
nature are among the most highly correlated with the true
neutrophil abundance. The complete granulocyte signa-
ture gene list and corresponding EASE analysis results are
available as supplemental data (see Additional file 2 for
gene list and Additional file 3 for EASE results).
Lymphocytes
We derived a lymphocyte signature by searching for genes
that met the following criteria: I) their expression was sig-
nificantly positively correlated with relative abundance of
lymphocytes across all samples II) their expression was
significantly different in PBMC samples than whole blood
samples (by SAM) and III) they were at least 2-fold more
highly expressed in PBMC than in whole blood. We
assumed that genes more highly expressed in PBMC sam-
ples than in whole blood were expressed by lymphocytes,
because their relative abundance is approximately 2.5 fold
higher in PBMC than in whole blood. Using these criteria,
we obtained a lymphocyte signature, consisting of 67
genes (represented by 77 clones) expressed more highly in
B-cells, CD4 T-cells, and CD8+ T-cells than in granulo-
cytes (Figure 6). In contrast to the other cell type signature
gene lists, this set of genes appeared to contain many uni-
versally expressed genes, whose transcripts comprised a
particularly large fraction of the total transcripts in these
cells, rather than genes known to be specific to a subset of
leukocytes. Genes encoding proteins involved in macro-
molecule biosynthesis, and ribosomal proteins in particu-
lar, were strikingly dominant in this signature (CYP17A1,
EEF2, RPL11, RPL21, RPL23, RPL27, RPL31, RPL35,
RPS14, RPS21, RPS24, RPS3A, RPS6, TGT, TPI1) and were
the most statistically significantly over-represented by
EASE analysis (top biological process GO annotation was
"macromolecule biosynthesis" and top cellular compo-
nent GO annotation was "cytosolic ribosome"). The dra-
matic difference in levels of expression of ribosomal
proteins between lymphocytes and granulocytes has been
previously reported in both SAGE [29,35]and microarray-
based studies [11]. Three components of the mitochon-
drial electron transport chain (UQCRB and COX6C,
COX7B) were also more highly expressed in lymphocytes
than granulocytes, a finding that is also consistent with aBMC Genomics 2006, 7:115 http://www.biomedcentral.com/1471-2164/7/115
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previous microarray study comparing whole blood and
PBMC [11]. These findings could reflect either elevated
levels of these transcripts in lymphocytes or unusually low
levels in granulocytes. Results from a survey of gene
expression in 35 human tissue types support the conclu-
sion that lymphocytes have elevated levels of transcripts
of genes involved in translation [36]. Perhaps lym-
phocytes maintain high levels of transcripts encoding the
translational apparatus in order to be ready to rapidly
ramp up the capacity for protein synthesis when activated.
The complete lymphocyte signature gene set and the cor-
responding EASE analysis results are available as supple-
mental data (see Additional file 2 for gene list and
Additional file 3 for EASE results).
Individual specific gene expression
Despite the small number of individuals sampled in this
study, we carried out a low power search for genes that
vary more in expression between individuals than
between cell types within an individual. The methods and
results of this analysis are available as supplemental data
Granulocyte signature genes Figure 5
Granulocyte signature genes. Relative expression of granulocyte signature genes is shown for all samples. Genes (rows) 
are sorted in descending order of correlation of gene expression with relative abundance of granulocytes. Samples (columns) 
are ordered in decreasing relative abundance from left to right. The grayscale bar on top shows the estimated relative abun-
dance of granulocytes in each class of samples – black indicates 100% relative abundance of granulocytes, white indicates 0% 
relative abundance of granulocytes, and grey indicates intermediate relative abundance of granulocytes. Gene expression values 
are centered across all samples to a median of zero. All genes mentioned in the text are listed in order of correlation with 
granulocyte abundance, and black bars indicate their positions in the figure.
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(see Additional file 5 for description, Additional file 6 for
text results, and Additional file 7 for figure of results).
Conclusion
By performing cDNA microarray analysis of purified sub-
populations of peripheral blood cells, we were able to
obtain global gene expression profiles of peripheral B-
Lymphocyte signature genes Figure 6
Lymphocyte signature genes. Relative expression of lymphocyte signature genes is shown for all samples. Genes (rows) 
are sorted in ascending order of descending correlation of gene expression with relative abundance of lymphocytes. Samples 
(columns) are ordered in increasing relative abundance from left to right. The grayscale bar on top shows the estimated rela-
tive abundance of lymphocytes in each class of samples – black indicates 100% relative abundance of lymphocytes, white indi-
cates 0% relative abundance of lymphocytes, and grey indicates intermediate relative abundance of lymphocytes. Gene 
expression values are centered across all samples to a median of zero. All genes mentioned in the text are listed and their posi-
tion is marked with a black bar.
                B CELLS                                      T CELLS                             PBMC              WB
C
O
R
R
E
L
A
T
I
O
N
EEF2
RPS24
RPL11
RPS6
UQCRB
CYP17A1
RPL21
TPI1
RPL35
RPL27
RPS3A
RPL31
RPS21
RPS14
COX6C
RPL23
TGT
COX7B
Theoretical % Abundance
0%    50%   100%
 
 
 
 
 
 
 
 
 
-4 fold        1x      +4 fold
Relative Gene ExpressionBMC Genomics 2006, 7:115 http://www.biomedcentral.com/1471-2164/7/115
Page 11 of 15
(page number not for citation purposes)
cells, T-cells, CD4+ T-cells, CD8+ T-cells, and granulocytes
from normal healthy donors. Both unsupervised cluster-
ing and supervised statistical analysis yielded sets of genes
highly preferentially expressed by each of these cell types.
Some characteristics of the genes comprising the signa-
tures we identified for of each of these cell types are sum-
marized in Table 1.
We found that, not surprisingly, the best gene expression
based surrogates for the abundance of a particular cell
subset were the expression of the genes associated with
the characteristic cell surface phenotype (e.g. CD8,
CD3D/G, CD20), or other genes known to be associated
with cell-type specific functions (such as cytotoxicity or
immunoglobulin secretion). While genes previously
known to be cell-type specific dominated the cell-type sig-
natures, they also contained numerous unannotated
genes, and genes not previously associated with the
known functional characteristics of the cells. It is interest-
ing to speculate on the significance of the finding that the
lymphocyte subset signatures (B-cells, T-cells, and CD8+
T-cells) were all dominated by genes encoding plasma-
membrane associated proteins. This may indicate that, in
their resting state, lymphocytes are specialized primarily
in the way they sense and monitor their environment.
This finding, together with the observation that lym-
phocytes have elevated levels of transcripts encoding
translational machinery, paints a picture of peripheral
blood lymphocytes spending the majority of their lives in
watchful waiting, while upon activation they respond rap-
idly are distinguished by their diverse effector roles.
While classical, direct methods of enumerating cell popu-
lations remain the simplest, and most accurate method of
characterizing the components of mixed cell populations,
the cell-type specific gene lists presented here provide an
alternative means of characterizing mixed cell popula-
tions that could be useful for profiling of archived RNAs
and heterogeneous clinical samples for which direct
counting is not possible. Furthermore, these cell type sig-
natures contribute significantly to functional annotations
of a substantial group of uncharacterized genes. Further
studies of the gene expression profiles of other purified
leukocyte populations such as NK cells and monocytes
will help establish the specialized gene expression pro-
grams that enable each cell type to perform its unique
function, and will further improve our ability to recon-
struct the cellular composition of heterogeneous samples.
Methods
Subjects
Blood samples from 3 female and 4 male volunteers were
obtained after informed consent. All volunteers were Cau-
casians, ranging in age from 22–45 years and self reported
as free of chronic and acute infections. Complete blood
counts were determined at the Stanford University Hospi-
tal Clinical Laboratory by automated procedures and have
been made available as supplemental data (see Additional
file 4). All subjects fell within normal ranges for the major
cell populations (% neutrophils, % lymphocytes, %
monocytes, % basophils, % eosinophils).
Isolation and purification of cell types
Purified cell subsets were derived from fresh whole blood
of healthy volunteers. We used Ficoll-Paque Plus (Phar-
macia Biotech) to enrich for peripheral blood mononu-
clear cells (PBMC) and incubation with magnetic mAb-
coated beads to further select for cell types of interest
(MACS, Miltenyi Biotech), according to manufacturer's
protocols. When possible, multiple cell types were simul-
taneously purified from a single donor. CD4+ T-cells and
CD8+ T-cells were isolated by negative selection: magnetic
depletion of non-target cells, B-cells were prepared both
by negative selection (depletion of non-B-cells) and by
positive selection – incubation of PBMC with anti-CD19
mAb-coated microbeads. Following purification, viability
and was assessed using Trypan Blue and was shown to be
>95% in all cases. Purity was assessed using flow cytome-
try and ranged from ~55–95%, depending on the cell
type's abundance in PBMC and the method of selection
(positive or negative). The resulting purified cell popula-
tions were suspended in a small volume of buffer, flash
Table 1: Gene list summary statistics "Contrasting Cell Pop." is the cell population to which the query cell population was compared in 
order to define the cell type signature list. "Genes" reports the number of genes that make up the gene expression signature that we 
defined for each cell type. "Correlation " reports the range and median correlation between expression levels of the signature genes 
and the relative abundance of the cognate cell type. "Fold Enrichment" reports the range and median ratio between the expression 
level of the genes in each cell type's signature and the "contrasting cell population" to which it was compared.
Cell type Contrasting cell pop. Genes Correlation Fold enrichment
B-cells T-cells 427 0.95-0.52 (0.81) 16.0-2.0 (2.9)
T-cells B-cells 222 0.92-0.50 (0.74) 18.4-2.0 (2.8)
CD8+ T-cells CD4+ T-cells 23 0.91-0.48 (0.67) 16.4-2.0 (2.6)
CD4+ T-cells CD8+ T-cells 0
Granulocytes (whole blood) PBMC 411 0.96-0.37 (0.74) 27.7-2.0 (2.8)
Lymphocytes (PBMC) Whole Blood 67 0.91-0.49 (0.76) 29.8-2.1 (3.3)BMC Genomics 2006, 7:115 http://www.biomedcentral.com/1471-2164/7/115
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frozen in liquid N2 and stored at -80 C. Each purification
yielded at least 1 × 106 cells of each subtype of interest.
Whole blood samples were obtained by extracting RNA
from 2.5 ml of with the PaxGene Blood RNA System (Pre-
AnalytiX, Hombrechtikon, Switzerland). Total RNA was
extracted from frozen PBMC and purified subsets using
RNeasy Total RNA Isolation Kit (Qiagen). Table 2 shows
the number of subjects and the median purity for each cell
subset.
Microarray procedures
Total RNA was linearly amplified twice as previously
described [37] with minor modifications. Fluorescent
(Cy5-labeled) cDNA probes were prepared from the
amplified RNA samples as described [38]and hybridized
to cDNA microarrays containing 37,632 array elements,
representing approximately 18,000 unique human genes
[39]. The cDNA microarrays were manufactured and
hybridized as previously described [38,40] (also see [41]).
A common reference RNA (Cy3-labeled) was mixed with
the Cy5-labeled experimental sample before hybridiza-
tion to provide a common internal reference standard for
comparison of relative gene expression levels across arrays
[38,40]. The reference was Stratagene Universal Human
Reference RNA – a mixture of RNA from 11 human cell
lines (Stratagene, La Jolla, CA). Fluorescence images of the
hybridized arrays were obtained using a GenePix 4000B
scanner (Axon Instruments, Union City, CA).
Data extraction and filtering
Gene expression measurements were extracted from the
fluorescent array images using GenePix Pro 5.0. Spots
with coefficients of variation greater than 0.95 in the Cy3
or the Cy5 channel were excluded from analysis, as were
spots that had >15% saturated pixels or that contained
fewer than 20 total pixels in either channel. Each array was
then subjected to normalization for dye effects: the fluo-
rescence ratios were multiplied by a constant such that the
average ratio of Cy5/Cy3 across a subset of high-confi-
dence spots was 1. The criterion for inclusion of data in
the initial dataset was a normalized intensity/background
ratio of at least 2.5 in the reference channel or the sample
channel. Prior to statistical analysis, data analysis was
restricted to genes for which at least 75% of the samples
had well measured data (as defined by the previously
described criteria). This filtering yielded 30,320 clones,
corresponding to ~16,865 unique genes (collapsed by
gene symbol). For pairwise cell type comparisons with
SAM, genes were further required to have 75% good data
in each of the relevant cell types. For intrinsic analysis,
genes were further required to have well measured data for
2 of the 3 cell types in each of the 5 individuals. For each
array, the log ratios were transformed such that the mean
log expression ratio of all elements on the array was zero.
For all clustering, the measurements for each gene (as log
ratios) were centered, by subtracting the mean across all
samples, in order to emphasize relative expression within
the experimental dataset.
Clones were collapsed to unique genes based on gene
symbol whenever possible, and otherwise using IMAGE
or LCP (lymphochip) clone numbers. Gene names were
converted to gene names and symbols using SOURCE
[42]. When reporting "gene" based results for gene lists,
the highest scoring (most correlated) clone is reported.
For the signature gene lists and intrinsic gene lists our final
filter was the removal of "outlier" genes: genes for which
there were 3 or more clones available on the microarray,
but only 1 gene was in the results list.
Significance analysis of microarrays
We used Significance Analysis of Microarrays (SAM) (Ver-
sion 1) to identify genes whose expression differed signif-
icantly between pairs of related cell types [18]. We
reported genes that differed between samples at median
false discovery rates of 5%. The lymphocyte versus granu-
locyte and B-cell versus T-cell comparisons employed the
two class unpaired analysis, while the CD4 versus CD8
analysis was for five paired samples from the same indi-
vidual. All comparisons used K-nearest neighbors to
impute missing data.
Pearson correlations
We used a custom perl script to calculate Pearson correla-
tions between the expression levels of each gene and the
relative abundance of each cell subset of interest. Since we
did not know the true relative abundance of each cell type
in each sample, we created relative abundance vectors for
each of CD4 T-cells, CD8 T-cells, B-cells, T-cells, and neu-
trophils based on perfect purifications for the purified
populations and average relative abundances for the
mixed cell populations. We first calculated the observed
Pearson correlation between expression levels for each
gene and each abundance vector. We then obtained signif-
icance values independently for each gene: parameter
Table 2: Sample purity Number of samples and median purity of 
each purified cell type as a percentage of all cells, measured by 
FACS. (+) or (-) refer to positive and negative selection 
respectively.
Selection Samples Male Female % Purity
CD4+ T-CELLS - 5 2 3 0.91
CD8+ T-CELLS - 6 2 4 0.86
B-CELLS (-) - 4 1 3 0.59
B-CELLS (+) + 5 3 2 0.88
PBMC 5 1 4 N/A
Whole blood 3 2 2 N/A
Overall 28 0.86BMC Genomics 2006, 7:115 http://www.biomedcentral.com/1471-2164/7/115
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pairwise correlation by permuting the query gene/param-
eter 10,000 times and calculating the percent of permuted
correlations that are more extreme (in either direction)
than the non-permuted (observed) correlation. We
reported genes with p < 0.005 (uncorrected) for the per-
mutation set. Table 3 lists the relative abundance esti-
mates used for correlation calculations.
EASE GO term annotation
We used EASE [19] to identify themes in the function and
cellular localization of genes comprising the signature
gene lists for each cell subset. We compared each gene list
to the same background file, which consisted of all genes
(16,865) that passed the 75% good data filter (described
in "Data Filtering" above) for the entire data set. All anal-
yses were done using gene symbol as the unique identi-
fier. In the supplemental data, we report all results for
which the Bonferroni corrected Fisher's Exact Probability
was less than 0.05 for each of the three ontologies -Molec-
ular Function, Biological Process, and Cellular Compo-
nent.
Abbreviations
GO: gene ontology; PBMC: peripheral blood mononu-
clear cell; SAM: Significance Analysis of Microarrays
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